ACTRN12614000546651
Terminated
未知
Does staging with 18F-FDG PET/CT and brain MRI alter the initial treatment proposal in melanoma patients with satellite or in-transit metastases as a first recurrence or at time of diagnosis? A prospective study.
Prof. John Francis Thompson0 sites25 target enrollmentMay 22, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Melanoma - In transit / satellite metastasis
- Sponsor
- Prof. John Francis Thompson
- Enrollment
- 25
- Status
- Terminated
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with cutaneous melanoma and clinically or pathologically confirmed satellite or in\-transit metastasis (N2c) without clinical evidence of metastases elsewhere (stage IIIB, C).
Exclusion Criteria
- •Clinical evidence of nodal or distant metastasis at time of enrolment.
- •Previous satellite or in\-transit metastasis.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The effectiveness of adding 18F-FDG PET/MRI to standard clinical care in patients with chronic low back or hip paiChronic pain10043237NL-OMON54240Erasmus MC, Universitair Medisch Centrum Rotterdam200
Completed
Not Applicable
Integrated 18F-FDG PET/CT in the staging of patients with suspected primary ovarian cancer.NL-OMON29961Academisch Ziekenhuis Maastricht20
Recruiting
Not Applicable
18F-FDG PET/CT versus CT imaging in staging of primary Muscle Invasive Bladder Cancerbladder cancerurothelial cell carcinoma10038364NL-OMON43864eids Universitair Medisch Centrum120
Withdrawn
Not Applicable
Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot StudyCholangiocarcinomaNCT00604266University of Toronto
Completed
Not Applicable
18F-FLT and 18F-FDG PET imaging for patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000010636Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui80